These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4848952)

  • 1. [Influence of SKF 525A on the kinetics and action of an antivitamin K in the rat].
    Thonnart N; Letist D; Reuse J
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):369-72. PubMed ID: 4848952
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparin-antivitamin K transfer].
    Fiessinger JN; Aïach M
    Rev Prat; 1988 May; 38(15):944, 947-51. PubMed ID: 3393836
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
    Cepeláková H; Roubal Z; Grimová J; Dlabac A; Cepelák V
    Acta Univ Carol Med Monogr; 1972; 52():55-60. PubMed ID: 4669827
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug interactions involving oral anticoagulants.
    O'Reilly RA
    Cardiovasc Clin; 1974; 6(2):23-41. PubMed ID: 4613460
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat].
    Thonnart N; Letist D; Reuse JJ
    C R Seances Soc Biol Fil; 1973; 167(6):1081-5. PubMed ID: 4803162
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of the progessive antithrombin during long-term anticoagulant therapy (Vitamin K antagonists)].
    Scheel H; Bergmann A; Wegner H
    Z Gesamte Inn Med; 1973 Feb; 28(3):38-41 passim. PubMed ID: 4633781
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of SKF 525A on the distribution of carbon tetrachloride in rats.
    Marchand C; McLean S; Plaa GL
    J Pharmacol Exp Ther; 1970 Aug; 174(2):232-8. PubMed ID: 5451360
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent developments in understanding the mechanism of vitamin K and vitamin K-antagonist drug action and the consequences of vitamin K action in blood coagulation.
    Jackson CM; Suttie JW
    Prog Hematol; 1977; 10():333-59. PubMed ID: 337364
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulation by oral treatment with vitamin K antagonists].
    Kemkes-Matthes B
    Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulants and drug interactions.
    Ebert RV
    Arch Intern Med; 1968 Apr; 121(4):373-4. PubMed ID: 5645713
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antivitamin K agents].
    Nicolas G
    Rev Prat; 1973 Dec; 23(60):5393-400. PubMed ID: 4794218
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitamin K and the oral anticoagulant drugs.
    O'Reilly RA
    Annu Rev Med; 1976; 27():245-61. PubMed ID: 779597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic studies in increased reactivity to phenprocoumon (Marcumar)].
    Chriske HW; von Smekal P; Knabe M; Kray D
    Med Welt; 1973 Oct; 24(42):1620-1. PubMed ID: 4764456
    [No Abstract]   [Full Text] [Related]  

  • 18. Determinants of the response to oral anticoagulant drugs in man.
    O'Reilly RA; Aggeler PM
    Pharmacol Rev; 1970 Mar; 22(1):35-96. PubMed ID: 4918964
    [No Abstract]   [Full Text] [Related]  

  • 19. Orally active direct thrombin inhibitors.
    Weitz J
    Semin Vasc Med; 2003 May; 3(2):131-8. PubMed ID: 15199476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation by SKF 525A of the pressor responses to catecholamines, oxytocin and carotid occlusion in rats.
    Krstić MK
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):52-62. PubMed ID: 6466007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.